GlobeNewswire Inc.··Pomerantz LlpSLNO Stock Plummets 39% Amid Fraud Allegations and Safety Concerns
Pomerantz LLP sues Soleno Therapeutics ($SLNO) over alleged securities fraud as stock plummets 39% following DCCR safety concerns and patient death disclosure. Lead Plaintiff deadline: May 5, 2026.
SLNOsecurities fraudclass action lawsuit